Senator Turns Up Heat On Genentech’s Decision To Curb Avastin Distribution
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA, CMS and Genentech drafting responses to inquiries from Sen. Herb Kohl, agency, CMS officials and Genentech tell “The Pink Sheet” DAILY.